Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") will hold its Annual General Meeting of shareholders ("AGM") at 10:30 a.m. CEST on May 21, 2026, at ...
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION 1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his ...
UroGen Pharma’s latest analyst update keeps the fair value target effectively anchored at US$35.63, with no reset in the central valuation estimate. Bullish voices see this as support for a ...
Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive ...
A bid for the world's largest music label, controversy over electronic shelf labels, OpenAI changes force marketers to pivot ...
Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, ...
India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the ...
Medicines can stop pain, fight cancer and save lives but are worthless if they get lost in the mail, spoil in a hot warehouse ...
The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...
The dedicated billing code, 0640U, effective July 1, 2026, establishes a unique reimbursement identifier for the CNSide CSF TCE test, supporting payer claims processing and facilitating broader ...
The new range will be presented together with its existing coding and marking equipment.